"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente San Leandro conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 66 clinical trials were completed, i.e. on average, 56.4% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 45 clinical trials were completed. i.e. 109.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente San Leandro" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "NRG Oncology" with 8 trials sponsored and "Gilead Sciences" with 8 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente San Leandro" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente San Leandro" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IIIA Breast Cancer" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Kaiser Permanente San Leandro" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente San Leandro" are "Drug" (125 trials), "Other" (96 trials), "Biological" (57 trials), "Procedure" (39 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (25 trials), "Carboplatin" (21 trials) and "Paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente San Leandro" are 128 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente San Leandro". undefined are not yet recruiting, 37 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Kaiser Permanente San Leandro, 4 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente San Leandro, 4 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".